NO991195L - Fremstilling av doseringsenheter ved bruk av lavskjaer-granulering - Google Patents

Fremstilling av doseringsenheter ved bruk av lavskjaer-granulering

Info

Publication number
NO991195L
NO991195L NO991195A NO991195A NO991195L NO 991195 L NO991195 L NO 991195L NO 991195 A NO991195 A NO 991195A NO 991195 A NO991195 A NO 991195A NO 991195 L NO991195 L NO 991195L
Authority
NO
Norway
Prior art keywords
granules
preparation
mixture
dosage units
low
Prior art date
Application number
NO991195A
Other languages
English (en)
Norwegian (no)
Other versions
NO991195D0 (no
Inventor
Herman Vromans
Hendrika Gerardi Poels-Janssen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO991195D0 publication Critical patent/NO991195D0/no
Publication of NO991195L publication Critical patent/NO991195L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
NO991195A 1998-03-12 1999-03-11 Fremstilling av doseringsenheter ved bruk av lavskjaer-granulering NO991195L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200790 1998-03-12

Publications (2)

Publication Number Publication Date
NO991195D0 NO991195D0 (no) 1999-03-11
NO991195L true NO991195L (no) 1999-09-13

Family

ID=8233460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991195A NO991195L (no) 1998-03-12 1999-03-11 Fremstilling av doseringsenheter ved bruk av lavskjaer-granulering

Country Status (15)

Country Link
US (1) US6054145A (hu)
JP (1) JPH11319035A (hu)
KR (1) KR19990077775A (hu)
CN (1) CN1238948A (hu)
AR (1) AR016454A1 (hu)
AU (1) AU2118199A (hu)
BR (1) BR9904552A (hu)
CA (1) CA2265211A1 (hu)
CZ (1) CZ88899A3 (hu)
HU (1) HUP9900598A2 (hu)
IL (1) IL128818A0 (hu)
NO (1) NO991195L (hu)
PL (1) PL331961A1 (hu)
SG (1) SG72938A1 (hu)
TR (1) TR199900548A2 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1177726A1 (en) * 2000-08-04 2002-02-06 Aventis Animal Nutrition S.A. Process for the production of granules of methionine
JP2002326925A (ja) * 2001-04-27 2002-11-15 Asahi Breweries Ltd 造粒物および錠剤の製造方法
ES2933479T3 (es) * 2003-09-29 2023-02-09 Novo Nordisk Healthcare Ag Estabilidad mejorada de formulaciones de progestágenos
DK1670440T3 (da) * 2003-09-29 2014-07-07 Novo Nordisk As HRT formuleringer
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
US20060002986A1 (en) * 2004-06-09 2006-01-05 Smithkline Beecham Corporation Pharmaceutical product
WO2006045152A1 (en) * 2004-10-29 2006-05-04 Mayne Pharma International Pty Ltd Improved tabletting process
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
CA2656019C (en) * 2006-06-28 2016-09-13 Emisphere Technologies, Inc. Gallium nitrate formulations
CN101810706B (zh) * 2009-05-26 2011-03-16 成都地奥制药集团有限公司 一种低剂量地榆固体制剂的制备方法
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
WO2020043732A1 (en) * 2018-08-30 2020-03-05 Boehringer Ingelheim International Gmbh Novel, lean and environment-friendly granulation method
US11167256B2 (en) 2019-07-01 2021-11-09 Oakwood Laboratories, Llc System and method for making microspheres and emulsions
US11330838B2 (en) 2019-07-19 2022-05-17 R. J. Reynolds Tobacco Company Holder for aerosol delivery device with detachable cartridge

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
DE69530308T2 (de) * 1994-09-22 2003-10-16 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Also Published As

Publication number Publication date
US6054145A (en) 2000-04-25
CZ88899A3 (cs) 1999-11-17
AR016454A1 (es) 2001-07-04
TR199900548A3 (tr) 1999-10-21
TR199900548A2 (xx) 1999-10-21
KR19990077775A (ko) 1999-10-25
IL128818A0 (en) 2000-01-31
JPH11319035A (ja) 1999-11-24
PL331961A1 (en) 1999-09-13
CN1238948A (zh) 1999-12-22
CA2265211A1 (en) 1999-09-12
SG72938A1 (en) 2000-05-23
AU2118199A (en) 1999-09-23
HUP9900598A2 (hu) 2001-06-28
HU9900598D0 (en) 1999-05-28
NO991195D0 (no) 1999-03-11
BR9904552A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
NO991195L (no) Fremstilling av doseringsenheter ved bruk av lavskjaer-granulering
AU594265B2 (en) Therapeutic compositions
RU2166936C2 (ru) Способ получения дозировочных единиц путем мокрой грануляции
RU1811401C (ru) Способ получени таблеток никорандила
CA2268626A1 (en) Pharmaceutical composition for rapid suspension in aqueous media
EA199700110A1 (ru) Композиция с высоким содержанием ацетаминофена для прямого прессования
CN101475420A (zh) 一种肥料水分散粒剂及其制备方法
NO933641L (no) Fremgangsmaate ved kjemisk strukturering av overflateaktive pastaer for aa danne hoeyaktive surfaktant-granuler
ES8301629A1 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".
JPH05503540A (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
EP1488697B1 (en) Granulated wettable powder
EP0394022B1 (en) Calcium pantothenate composit
JP2626975B2 (ja) 低融点油性物質含有錠剤
Egermann et al. Effects of interparticulate interactions on mixing homogeneity
EP0735864B1 (en) Method for preparing low dose pharmaceutical products
CA1235065A (en) Stabilized 4-carbamoyl-imidazolium-5-olate preparations
DE3378741D1 (en) Processes for preparing tablets by a modified 'wet-granulation' technique
TW307665B (hu)
CN101732236A (zh) 一种预防结块变色的固体药物制剂及其制备方法
CN109260169A (zh) 一种缬沙坦氨氯地平片剂及其制备方法
CN105267167A (zh) 一种瑞戈非尼口服固体药物组合物的制备方法
AU663000B2 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
KR890007745A (ko) 약학조성물 및 그의 제조방법
CN109730061A (zh) 一种农药颗粒剂的稳定剂及其应用
谷沢欽次 et al. Chemical and physical release control of destosyl pyrazolate (DTP) in paddy fields by pyrazolate granules

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application